Suramin in Treating Patients With Recurrent Primary Brain Tumors
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of suramin in treating patients with
recurrent primary brain tumors following radiation therapy.